These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 6405439

  • 1. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.
    Spyraki C, Fibiger HC, Phillips AG.
    Psychopharmacology (Berl); 1983; 79(2-3):278-83. PubMed ID: 6405439
    [Abstract] [Full Text] [Related]

  • 2. A role for the mesolimbic dopamine system in the reinforcing properties of diazepam.
    Spyraki C, Fibiger HC.
    Psychopharmacology (Berl); 1988; 94(1):133-7. PubMed ID: 3126522
    [Abstract] [Full Text] [Related]

  • 3. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C, Fibiger HC, Phillips AG.
    Brain Res; 1982 Dec 16; 253(1-2):185-93. PubMed ID: 6817850
    [Abstract] [Full Text] [Related]

  • 4. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
    Kalivas PW, Bronson M.
    Neuropharmacology; 1985 Oct 16; 24(10):931-6. PubMed ID: 3934576
    [Abstract] [Full Text] [Related]

  • 5. Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats.
    Fink JS, Smith GP.
    Neurosci Lett; 1980 Apr 16; 17(1-2):61-5. PubMed ID: 6820483
    [Abstract] [Full Text] [Related]

  • 6. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats.
    Pettit HO, Ettenberg A, Bloom FE, Koob GF.
    Psychopharmacology (Berl); 1984 Apr 16; 84(2):167-73. PubMed ID: 6438676
    [Abstract] [Full Text] [Related]

  • 7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 16; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 8. 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine.
    Taylor JR, Robbins TW.
    Psychopharmacology (Berl); 1986 Jan 16; 90(3):390-7. PubMed ID: 3097729
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH, Swerdlow NR, Koob GF.
    Behav Neurosci; 1988 Aug 16; 102(4):544-52. PubMed ID: 3139012
    [Abstract] [Full Text] [Related]

  • 14. Mesolimbic dopamine and early post-6-OHDA lesion enhanced responses to d-amphetamine.
    Lynch MR, Carey RJ.
    Pharmacol Biochem Behav; 1989 Feb 16; 32(2):577-80. PubMed ID: 2498910
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dopaminergic mediation of reward produced by direct injection of enkephalin into the ventral tegmental area of the rat.
    Phillips AG, LePiane FG, Fibiger HC.
    Life Sci; 1983 Dec 19; 33(25):2505-11. PubMed ID: 6417434
    [Abstract] [Full Text] [Related]

  • 17. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.
    French ED, Pilapil C, Quirion R.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):1-9. PubMed ID: 2996909
    [Abstract] [Full Text] [Related]

  • 18. Role for dopamine neurons of the rostral linear nucleus and periaqueductal gray in the rewarding and sensitizing properties of heroin.
    Flores JA, Galan-Rodriguez B, Ramiro-Fuentes S, Fernandez-Espejo E.
    Neuropsychopharmacology; 2006 Jul 08; 31(7):1475-88. PubMed ID: 16292327
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.